The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin

Mostrar otras versiones (1)

Tumour progression and therapy resistance in squamous cell carcinoma of the skin (SCC) is strongly associated with resistance to intrinsic mitochondrial apoptosis. We thus investigated the role of various anti-apoptotic Bcl-2 proteins for apoptosis protection in SCC using the BH3 agonist ABT737 that...

Descripción completa

Detalles Bibliográficos
Autores principales: Geserick, P, Wang, J, Feoktistova, M, Leverkus, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540197/
https://www.ncbi.nlm.nih.gov/pubmed/25210795
http://dx.doi.org/10.1038/cddis.2014.379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540197/
https://www.ncbi.nlm.nih.gov/pubmed/25210795
http://dx.doi.org/10.1038/cddis.2014.379

Ejemplares similares